Sarepta Therapeutics: Q1 Earnings Insights

Comments
Loading...

Sarepta Therapeutics SRPT reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Sarepta Therapeutics beat estimated earnings by 55.91%, reporting an EPS of $-0.56 versus an estimate of $-1.27.

Revenue was up $63.90 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.36 which was followed by a 4.66% increase in the share price the next day.

Here's a look at Sarepta Therapeutics's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -1.13 -1.89 -1.29 -1.78
EPS Actual -0.77 -0.19 -1.52 -1.54
Revenue Estimate 198.61M 173.42M 162.64M 143.33M
Revenue Actual 201.46M 189.41M 164.09M 146.93M

To track all earnings releases for Sarepta Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Overview Rating:
Speculative
37.5%
Technicals Analysis
66
0100
Financials Analysis
20
0100
Overview
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!